Northwest Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Northwest Biotherapeutics's estimated annual revenue is currently $1.7M per year.
- Northwest Biotherapeutics's estimated revenue per employee is $70,833
- Northwest Biotherapeutics's total funding is $169.4M.
Employee Data
- Northwest Biotherapeutics has 24 Employees.
- Northwest Biotherapeutics grew their employee count by 9% last year.
Northwest Biotherapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP Business Development | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Technical Officer | Reveal Email/Phone |
5 | Director Information Technology | Reveal Email/Phone |
6 | Office Manager | Reveal Email/Phone |
7 | Sr. Controller | Reveal Email/Phone |
8 | Patient Advocate | Reveal Email/Phone |
Northwest Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Northwest Biotherapeutics?
Northwest Biotherapeutics is developing two drug platforms -- DCVax and HuRx -- based on monoclonal antibodies. The company's patented monoclonal antibodies are designed to attach to cancer-causing antigens and kill cancer cells in cancers ranging from prostate and brain cancer to skin and breast cancer.
keywords:N/A$169.4M
Total Funding
24
Number of Employees
$1.7M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Northwest Biotherapeutics News
2022-04-19 - Ovarian Cancer Diagnostics Technologies Market Size ...
... Forecast | Adgero Biopharmaceuticals, Cellceutix, Roche, Natco Pharma, Northwest Biotherapeutics, Pfizer, Sumitomo Dainippon Pharma, VG Life Sciences.
2022-04-17 - Counsel Leadership Fight Looms In Pharma Co. Pay Suit
Northwest Biotherapeutics Inc. and the directors are represented by Raymond J. DiCamillo, Rudolf Koch, Alexander M. Krischik, and Sandy Xu of...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 24 | -4% | N/A |
#2 | $3.8M | 24 | -25% | N/A |
#3 | $3.5M | 24 | 0% | N/A |
#4 | $2.7M | 24 | -17% | $116M |
#5 | $4.5M | 24 | -8% | N/A |
